Joao Luiz Paschoal Head of Practices - Companies
london
English, Portuguese
About Joao
As Head of Financial Services & Companies Practice, I set research best-practice, steer high-impact projects, and grow our Financial & Investment solutions, while leading and developing a specialist consultant team.
Expertise
Seasoned consultant steering strategy and company analysis across financial services, food & beverage, healthcare, industrial, consumer goods and retail, converting sharp market insights into measurable growth Global Head of Financial Services & M&A at Euromonitor, Joao draws on 10+ years and 150+ deals to lead IPOs, private placements and M&A, advising clients on capital raises, target screening and growth strategy worldwide
Related to Industries
The Diffusion Principle: How Nootropic Claims Are Crossing Industry Boundaries
29 Jan 26Success in claim innovation isn't measured solely by volume, but also by reach. When a functional claim established in one industry migrates across category boundaries, you know it has transcended niche status to become a general consumer expectation. Nootropic claims are doing this, and the diffusion pattern shows something important about how health and wellness trends achieve mainstream traction.
Miri Eliyahu
Generative AI is Revolutionising the Digital Shopper Journey
28 Jan 26As GenAI surges in popularity, more consumers are utilising GenAI platforms in place of traditional search engines when searching for products and services to buy online. Thanks to advancements in in-chat payments, consumers are also increasingly conducting transactions directly within GenAI platforms. These developments are forcing brands and retailers to embrace GenAI to an unprecedented degree, powering an extraordinary transformation in digital commerce.
Bob Hoyler
Top Five Trends Shaping Staple Foods into 2026
28 Jan 26With affordability concerns continuing to mount and eating habits being rewritten, the staple foods landscape is entering a new era. Affordability drives sales, with consumers favouring lower-cost options and producers facing challenges in creating volume growth. Changing perceptions of ultra-processed foods, demographic shifts, and rising use of GLP-1 weight loss drugs also influence demand heading into 2026.
Tom Rees